Evidence map›Paper›PMID 25233145›Full record

ArticleAnalytical chemistry2014

Reproducible automated phosphopeptide enrichment using magnetic TiO2 and Ti-IMAC.

Christopher J Tape, Jonathan D Worboys, John Sinclair, Robert Gourlay, Janis Vogt, Kelly M McMahon, Matthias Trost, Douglas A Lauffenburger, Douglas J Lamont, Claus Jørgensen

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome.Journal of cardiovascular development and disease · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Leveraging HILIC/ERLIC separations for online nanoscale LC-MS/MS analysis of phosphopeptide isoforms from RNA polymerase II C-terminal domain.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Automated Immunoprecipitation Workflow for Comprehensive Acetylome Analysis.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Christopher J TapeThe Institute of Cancer Research , 237 Fulham Road, London SW3 6JB, United Kingdom.
Jonathan D Worboys
John Sinclair
Robert Gourlay
Janis Vogt
Kelly M McMahon
Matthias Trost
Douglas A Lauffenburger
Douglas J Lamont
Claus Jørgensen
Institute of Cancer Research · GB

Funding

Engineered Antibody EGFR Antagonist Cancer TherapeuticsR01CA096504 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WITTRUP, KARL DANE · 2002 to 2017
$9.7M
Cancer Research UK 12905Cancer Research UK C37293/A12905Medical Research Council G1100713Medical Research Council MC_UP_A500_1020Medical Research Council MC_UU_12016/5NCI NIH HHS R01 CA096504Wellcome TrustWellcome Trust 098847/Z/12/Z
6 · The paper itself

Abstract

Reproducible, comprehensive phosphopeptide enrichment is essential for studying phosphorylation-regulated processes. Here, we describe the application of hyper-porous magnetic TiO2 and Ti-IMAC microspheres for uniform automated phosphopeptide enrichment. Combining magnetic microspheres with a magnetic particle-handling robot enables rapid (45 min), reproducible (r2 ≥ 0.80) and high-fidelity (>90% purity) phosphopeptide purification in a 96-well format. Automated phosphopeptide enrichment demonstrates reproducible synthetic phosphopeptide recovery across 2 orders of magnitude, "well-to-well" quantitative reproducibility indistinguishable to internal SILAC standards, and robust "plate-to-plate" reproducibility across 5 days of independent enrichments. As a result, automated phosphopeptide enrichment enables statistical analysis of label-free phosphoproteomic samples in a high-throughput manner. This technique uses commercially available, off-the-shelf components and can be easily adopted by any laboratory interested in phosphoproteomic analysis. We provide a free downloadable automated phosphopeptide enrichment program to facilitate uniform interlaboratory collaboration and exchange of phosphoproteomic data sets.

Indexed as

MagneticsAutomationImidazolesMultivariate AnalysisPhosphopeptidesProteomicsReproducibility of ResultsTitaniumimidazoleacetic acidImidazolesPhosphopeptidesTitaniumtitanium dioxide

Identifiers

PMID25233145
PMCPMC4206527
OpenAlexW1528636076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.